A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis (Ocarina)
Posted Date: Oct 7, 2019
- Investigator: Lawrence Goldstick
- Specialties: Multiple Sclerosis, Neurology
- Type of Study: Drug
A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis
Criteria:
Patients With Multiple Sclerosis Previously Treated With Ocrelizumab For At Least One Year, Or Patients Who Have Never Received Ocrelizumab
Keywords:
Primary Progressive Ms, Relapsing Remitting Ms
For More Information:
Melissa Gilchrist
9375355014
melissa.gilchrist@uchealth.com